Stay updated on APL-2 Efficacy & Safety in PNH Patients Clinical Trial
Sign up to get notified when there's something new on the APL-2 Efficacy & Safety in PNH Patients Clinical Trial page.

Latest updates to the APL-2 Efficacy & Safety in PNH Patients Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedLocations section was updated with added sites across the US, Australia, Belgium, Canada, France, Germany, Japan and other regions, and some sites were removed. The study record revision was updated from v3.3.2 to v3.3.3.SummaryDifference2%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedPublications are now described as automatically populated from PubMed and may not all be about the study. The page revision line shows Revision: v3.3.2.SummaryDifference0.1%

- Check51 days agoChange DetectedDeleted the government funding status notice from the page, and core study details such as design, endpoints, and eligibility remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check65 days agoChange DetectedNo significant changes detected on the Study Details page for NCT03500549. Core information such as the study title, conditions, interventions, eligibility criteria, and locations appears unchanged.SummaryDifference0.3%

- Check94 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference2%

- Check101 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.0%

Stay in the know with updates to APL-2 Efficacy & Safety in PNH Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 Efficacy & Safety in PNH Patients Clinical Trial page.